BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  Response Genetics, Inc. Announces Appointment of James Wynne as Vice President, Sales & Marketing

  October 2, 2012

   · 

  4 min read
• Addex Therapeutics and Collaborators Awarded Swiss CTI Grant to Develop Allosteric Modulators for Neurodegenerative and Psychiatric Diseases

  October 2, 2012

   · 

  7 min read
• Policy

  Questcor Pharmaceuticals, Inc. (Headquarters) Investor Lawsuit Over Alleged False and Misleading Statements Announced by Shareholders Foundation

  October 2, 2012

   · 

  2 min read
• Drug Development

  Neurocrine Biosciences, Inc. Announces Start of Phase IIb Study of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia

  October 2, 2012

   · 

  6 min read
• BioCapital

  Nuvilex Subsidiary Austrianova Singapore to Participate in AusBiotech 2012

  October 2, 2012

   · 

  1 min read
• Business

  Sunesis Pharmaceuticals, Inc. Announces Management Promotions

  October 2, 2012

   · 

  1 min read
• Bio NC

  DARA BioSciences, Inc. Regains Compliance With NASDAQ $1.00 Minimum Bid Price Rule

  October 2, 2012

   · 

  1 min read
• Drug Development

  Aduro Biotech Announces First Patient Enrolled in Mesothelioma Clinical Trial

  October 2, 2012

   · 

  1 min read
• Pharm Country

  Welch Allyn’s New Ophthalmic Imaging Product Integrates Advanced Eye Exam Technology With iPhone™ Application

  October 2, 2012

   · 

  1 min read
• Drug Development

  TSI Initiates Phase 1 Study of New-Generation Thrombolytic, TS01

  October 2, 2012

   · 

  3 min read